Subscribe To
Apple wins appeal against uk's decision to investigate its mobile browser
Apple Inc won its appeal against the decision by Britain's antitrust regulator to launch an investigati...
March 31, 2023, 12:41 pm
Realsage secures $2.1 million cad to help multi-family rental managers make better decisions with ai
Toronto-based proptech startup RealSage has closed $2.1 million CAD ($1.6 million USD) in pre-seed funding to fuel its North American expansion and pr...
March 31, 2023, 10:14 am
Forex sentiment analysis robot mt4 : ea for smart trading
Forex Sentiment Analysis Robot Review In the world of forex trading, traders are always looking for an edge. With the market constantly changing, it c...
March 31, 2023, 8:30 am
Road to the app store: how metaquotes succeeded where others did not
On September 24, 2022, the MetaTrader4 (MT4) and MetaTrader5 (MT5) trading platforms were withdrawn from the App Store, Apple’s...
March 31, 2023, 8:22 am
British gas loses high court wrangle over bulb
British Gas owner, Centrica PLC, and two other major energy suppliers have lost their High Court challenge over the UK government's handling of the s...
March 31, 2023, 7:22 am
Eur/gbp daily outlook
Daily Pivots: (S1) 0.8780; (P) 0.8804; (R1) 0.8828; More… Intraday bias in EUR/GBP remains neutral at this point. Also, near term outlook is mixed. ...
March 31, 2023, 6:44 am
Eur/aud daily outlook
Daily Pivots: (S1) 1.6156; (P) 1.6235; (R1) 1.6327; More… Immediate focus is now on 61.8% projection of 1.4281 to 1.5976 from 1.5254 at 1.6302 .
March 31, 2023, 6:42 am
Aud/usd daily report
Daily Pivots: (S1) 0.6677; (P) 0.6697; (R1) 0.6733; More… Intraday bias in AUD/USD stays neutral as range trading continues. Deeper decline is in fa...
March 31, 2023, 6:20 am
Eur/usd daily outlook
Daily Pivots: (S1) 1.0818; (P) 1.0845; (R1) 1.0872; More… Focus remains on 1.0929 resistance in EUR/USD. Break there will resume the rally from 1.05...
March 31, 2023, 6:09 am
Gbp/usd daily outlook
Daily Pivots: (S1) 1.2324; (P) 1.2359; (R1) 1.2423; More… GBP/USD’s rally continues today and intraday bias stays on the upside for 1.2445/6 resis...
March 31, 2023, 5:19 am
Buy crispr therapeutics on approval odds
CTX001 has progressed enough to start discussing details regarding the launch of the program. Regulatory decis...
March 31, 2023, 4:07 am
Current price of silver today (pakistan rupee)
Historical silver prices are provided for context and to help inform investment decisions. Gold Eagle h...
March 31, 2023, 3:59 am
Fed barkin: i’m comfortable with the trajectory we’re on now
Richmond Fed President Thomas Barkin expressed his comfort with Fed’s current approach to interest rate hikes, stating, “I’m comfortable with th...
March 31, 2023, 3:48 am
Canada’s decision on rogers-shaw deal may come on friday
(Reuters) – Canadian Minister of Innovation, Science and Industry Francois-Philippe Champagne is set to rule on Rogers Communications Inc’s C$20 b...
March 31, 2023, 2:30 am
Rba to hike rates 25 bps on april 4 but decision on a knife edge- reuters poll
By Shaloo Shrivastava BENGALURU (Reuters) – Australia’s central bank is expected to go for a final 25 basis point interest rate hike to 3.85% on T...
March 31, 2023, 12:15 am
Omega accounting solutions named #1 best erc company for erc refunds
Merchant Maverick recognizes Omega for its exceptional customer care and bridge-loan services IRVINE, Calif., March 30, 2023 (GLOBE NEWSWIRE) — Omeg...
March 31, 2023, 12:02 am
Us court sanctions google in privacy case, company's second legal setback in days
A U.S. court has sanctioned Google LLC for a second time in recent days, after a judge in a decision un...
March 30, 2023, 4:50 pm
Gbp/usd mid-day outlook
Daily Pivots: (S1) 1.2292; (P) 1.2327; (R1) 1.2351; More… Intraday bias in GBP/USD remains on the upside for retesting 1.2445/6 resistance zone.
March 30, 2023, 1:39 pm
Charles schwab stock declines on morgan stanley downgrade
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss a Morgan Stanley analyst's decision to do...
March 30, 2023, 9:55 am
Pacira's (pcrx) snda for exparel accepted for fda review
The FDA accepts Pacira's (PCRX) sNDA filing, which seeks to expand the label of its pain drug Exparel to include both sciatic and femoral nerve blocks...
March 30, 2023, 9:54 am